Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Conference/Events
Needham to hold a virtual conference » 09:12
04/12/21
04/12
09:12
04/12/21
09:12
GRCL

Gracell

$13.52 /

-0.82 (-5.72%)

, LMAT

LeMaitre

$51.38 /

+0.82 (+1.62%)

, IONS

Ionis Pharmaceuticals

$42.32 /

-0.32 (-0.75%)

, TSHA

Taysha Gene Therapies

$21.35 /

+1.49 (+7.50%)

, ZEAL

Zealand Pharma

$33.60 /

+1.27 (+3.93%)

, CLSD

Clearside Biomedical

$2.66 /

+0.12 (+4.72%)

, MEIP

MEI Pharma

$3.43 /

+0.12 (+3.63%)

, PCVX

Vaxcyte

$20.27 /

-0.49 (-2.36%)

, EVLO

Evelo Biosciences

$10.03 /

+0.005 (+0.05%)

, IVC

Invacare

$8.23 /

-0.08 (-0.96%)

, BSGM

BioSig Technologies

$4.59 /

+0.12 (+2.68%)

, CYTK

Cytokinetics

$24.17 /

+0.01 (+0.04%)

, SYBX

Synlogic

$3.34 /

-0.02 (-0.60%)

, RNA

Avidity Biosciences

$22.12 /

-1.8 (-7.53%)

, CSTL

Castle Biosciences

$69.44 /

-1.2 (-1.70%)

, AGI

Alamos Gold

$8.37 /

+0.08 (+0.97%)

, CARA

Cara Therapeutics

$29.09 /

+1.645 (+5.99%)

, FIX

Comfort Systems USA

$79.11 /

+1.925 (+2.49%)

, ITRM

Iterum Therapeutics

$1.30 /

-0.305 (-19.00%)

, LTRN

Lantern Pharma

$17.05 /

-0.13 (-0.76%)

, OCGN

Ocugen

$6.96 /

+0.045 (+0.65%)

, QURE

uniQure

$33.77 /

-1.75 (-4.93%)

, STTK

Shattuck Labs

$28.31 /

+1.365 (+5.07%)

, VKTX

Viking Therapeutics

$5.93 /

-0.23 (-3.73%)

20th Annual Virtual…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GRCL Gracell
$13.52 /

-0.82 (-5.72%)

LMAT LeMaitre
$51.38 /

+0.82 (+1.62%)

IONS Ionis Pharmaceuticals
$42.32 /

-0.32 (-0.75%)

TSHA Taysha Gene Therapies
$21.35 /

+1.49 (+7.50%)

ZEAL Zealand Pharma
$33.60 /

+1.27 (+3.93%)

CLSD Clearside Biomedical
$2.66 /

+0.12 (+4.72%)

MEIP MEI Pharma
$3.43 /

+0.12 (+3.63%)

PCVX Vaxcyte
$20.27 /

-0.49 (-2.36%)

EVLO Evelo Biosciences
$10.03 /

+0.005 (+0.05%)

IVC Invacare
$8.23 /

-0.08 (-0.96%)

BSGM BioSig Technologies
$4.59 /

+0.12 (+2.68%)

CYTK Cytokinetics
$24.17 /

+0.01 (+0.04%)

SYBX Synlogic
$3.34 /

-0.02 (-0.60%)

RNA Avidity Biosciences
$22.12 /

-1.8 (-7.53%)

CSTL Castle Biosciences
$69.44 /

-1.2 (-1.70%)

AGI Alamos Gold
$8.37 /

+0.08 (+0.97%)

CARA Cara Therapeutics
$29.09 /

+1.645 (+5.99%)

FIX Comfort Systems USA
$79.11 /

+1.925 (+2.49%)

ITRM Iterum Therapeutics
$1.30 /

-0.305 (-19.00%)

LTRN Lantern Pharma
$17.05 /

-0.13 (-0.76%)

OCGN Ocugen
$6.96 /

+0.045 (+0.65%)

QURE uniQure
$33.77 /

-1.75 (-4.93%)

STTK Shattuck Labs
$28.31 /

+1.365 (+5.07%)

VKTX Viking Therapeutics
$5.93 /

-0.23 (-3.73%)

GRCL Gracell
$13.52 /

-0.82 (-5.72%)

02/03/21 Citi
Gracell initiated with a Buy at Citi
02/02/21 Jefferies
Gracell initiated with a Buy at Jefferies
02/02/21 Wells Fargo
Gracell initiated with an Overweight at Wells Fargo
02/02/21 Piper Sandler
Gracell initiated with an Overweight at Piper Sandler
LMAT LeMaitre
$51.38 /

+0.82 (+1.62%)

02/26/21 Barrington
LeMaitre price target raised to $49 from $47 at Barrington
02/12/21
Fly Intel: Top five analyst initiations
02/12/21 KeyBanc
LeMaitre initiated with a Sector Weight at KeyBanc
02/11/21 KeyBanc
LeMaitre initiated with a Sector Weight at KeyBanc
IONS Ionis Pharmaceuticals
$42.32 /

-0.32 (-0.75%)

03/29/21 Piper Sandler
Ionis' Phase 2 data for PKK-LRx 'impressive' at face value, says Piper Sandler
03/29/21 RBC Capital
PTC Therapeutics upgraded to Sector Perform at RBC Capital on valuation
03/23/21 Truist
Truist sees mixed readthroughs to Wave's toplines from competitor HD setback
03/23/21 BMO Capital
Ionis Pharmaceuticals price target lowered to $76 from $90 at BMO Capital
TSHA Taysha Gene Therapies
$21.35 /

+1.49 (+7.50%)

03/04/21 Chardan
Taysha Gene Therapies price target raised to $60 from $45 at Chardan
02/23/21 William Blair
William Blair starts Taysha with Outperform, $46 fair-value estimate
02/23/21 William Blair
William Blair starts Taysha Gene Therapies with Outperform on positive FDA draft
02/23/21 William Blair
Taysha Gene Therapies initiated with an Outperform at William Blair
ZEAL Zealand Pharma
$33.60 /

+1.27 (+3.93%)

CLSD Clearside Biomedical
$2.66 /

+0.12 (+4.72%)

03/02/21 Roth Capital
Clearside enrollment speed 'encouraging,' says Roth Capital
12/03/20 Roth Capital
Clearside platform validated by Janssen deal, says Roth Capital
08/06/20 Roth Capital
Investors should buy 'highly undervalued' Clearside, says Roth Capital
06/19/20 Roth Capital
Clearside Biomedical abstracts highlight strength, says Roth Capital
MEIP MEI Pharma
$3.43 /

+0.12 (+3.63%)

10/12/20 Brookline
MEI Pharma initiated with a Buy at Brookline
09/22/20 Alliance Global Partners
MEI Pharma initiated with a Buy at Alliance Global Partners
07/06/20 SunTrust
MEI Pharma price target lowered to $12 from $16 at SunTrust
05/29/20
Fly Intel: Top five analyst initiations
PCVX Vaxcyte
$20.27 /

-0.49 (-2.36%)

07/16/20 Wells Fargo
Sutro Biopharma initiated with an Overweight at Wells Fargo
07/07/20
Fly Intel: Top five analyst initiations
07/07/20 BofA
Vaxcyte initiated with a Buy at BofA
07/07/20 Jefferies
Vaxcyte initiated with a Buy at Jefferies
EVLO Evelo Biosciences
$10.03 /

+0.005 (+0.05%)

07:52 Today Jefferies
Jefferies upgrades Evelo Biosciences to Buy on increased microbiome momentum
04:50 Today Jefferies
Evelo Biosciences upgraded to Buy from Hold at Jefferies
03/12/21 Chardan
Evelo Biosciences price target raised to $15 from $10 at Chardan
01/25/21 JMP Securities
Evelo Biosciences price target raised to $36 from $27 at JMP Securities
IVC Invacare
$8.23 /

-0.08 (-0.96%)

BSGM BioSig Technologies
$4.59 /

+0.12 (+2.68%)

CYTK Cytokinetics
$24.17 /

+0.01 (+0.04%)

03/11/21 Wolfe Research
Cytokinetics initiated with an Outperform at Wolfe Research
02/18/21 Barclays
Cytokinetics initiated with an Overweight at Barclays
01/20/21 H.C. Wainwright
Cytokinetics price target raised to $41 from $22 at H.C. Wainwright
12/28/20 Oppenheimer
Amgen price target lowered to $266 from $274 at Oppenheimer
SYBX Synlogic
$3.34 /

-0.02 (-0.60%)

03/25/21 SVB Leerink
Synlogic price target raised to $15 from $10 at SVB Leerink
03/18/21 JonesTrading
Synlogic initiated with a Buy at JonesTrading
01/13/21 Chardan
Chardan doubles Synlogic target to $10, names top 2021 pick
09/18/20 Chardan
Seres Therapeutics downgraded to Neutral from Buy at Chardan
RNA Avidity Biosciences
$22.12 /

-1.8 (-7.53%)

07/07/20 Cowen
Avidity Biosciences initiated with an Outperform at Cowen
07/07/20 SVB Leerink
Avidity Biosciences initiated with an Outperform at SVB Leerink
07/07/20 Cowen
Avidity Biosciences initiated with an Outperform at Cowen
07/07/20 Wells Fargo
Avidity Biosciences initiated with an Overweight at Wells Fargo
CSTL Castle Biosciences
$69.44 /

-1.2 (-1.70%)

03/09/21 Baird
Castle Biosciences price target lowered to $82 from $87 at Baird
02/03/21 KeyBanc
Castle Biosciences price target raised to $90 from $70 at KeyBanc
01/26/21 Canaccord
Castle Biosciences price target raised to $84 from $80 at Canaccord
01/15/21 SVB Leerink
Castle Biosciences price target raised to $80 from $70 at SVB Leerink
AGI Alamos Gold
$8.37 /

+0.08 (+0.97%)

02/10/21 JPMorgan
Alamos Gold initiated with a Neutral at JPMorgan
02/08/21 CIBC
Alamos Gold price target lowered to C$16 from C$19.25 at CIBC
02/02/21 National Bank
Alamos Gold price target lowered to C$14.50 from C$15.50 at National Bank
01/11/21 National Bank
Alamos Gold price target lowered to C$15.50 from C$16 at National Bank
CARA Cara Therapeutics
$29.09 /

+1.645 (+5.99%)

12/29/20 H.C. Wainwright
H.C. Wainwright reiterates $33 target on Cara after new drug filing
10/20/20 H.C. Wainwright
Cara deal with 'perfect partner' Vifor boosts confidence at H.C. Wainwright
04/22/20 Cantor Fitzgerald
Cara Therapeutics price target raised to $34 from $26 at Cantor Fitzgerald
04/21/20 H.C. Wainwright
Cara Therapeutics price target raised to $33 from $30 at H.C. Wainwright
FIX Comfort Systems USA
$79.11 /

+1.925 (+2.49%)

07/29/20 DA Davidson
Comfort Systems USA price target raised to $45 from $32 at DA Davidson
04/29/20 DA Davidson
Comfort Systems USA downgraded to Neutral from Buy at DA Davidson
04/29/20 DA Davidson
Comfort Systems USA downgraded to Neutral from Buy at DA Davidson
04/20/20 Sidoti
Comfort Systems USA downgraded to Neutral from Buy at Sidoti
ITRM Iterum Therapeutics
$1.30 /

-0.305 (-19.00%)

03/15/21 H.C. Wainwright
Iterum Therapeutics upgraded to Buy from Neutral at H.C. Wainwright
12/24/20 H.C. Wainwright
Iterum CSO resignation 'somewhat troubling,' says H.C. Wainwright
06/16/20 H.C. Wainwright
Iterum Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
06/02/20 RBC Capital
Iterum Therapeutics downgraded to Sector Perform from Outperform at RBC Capital
LTRN Lantern Pharma
$17.05 /

-0.13 (-0.76%)

08/10/20 ThinkEquity
Lantern Pharma initiated with a Buy at ThinkEquity
07/28/20 Colliers
Drug 'rescuer' Lantern Pharma started at Buy at Colliers
07/28/20 Colliers
Lantern Pharma initiated with a Buy at Colliers
OCGN Ocugen
$6.96 /

+0.045 (+0.65%)

03/31/21
Ocugen participates in a conference call with Cantor Fitzgerald
03/16/21 Roth Capital
Covaxin chances of U.S. approval now increased, says Roth Capital
03/04/21 Roth Capital
Ocugen price target raised to $10 from $9 at Roth Capital
03/04/21 Roth Capital
Roth boosts Ocugen target after partnered vaccine shows 'broad' efficacy
QURE uniQure
$33.77 /

-1.75 (-4.93%)

04/01/21
Fly Intel: Top five analyst upgrades
04/01/21 Mizuho
uniQure upgraded to Buy on favorable risk/reward at Mizuho
04/01/21 Mizuho
uniQure upgraded to Buy from Neutral at Mizuho
03/29/21 H.C. Wainwright
uniQure probe 'important first step' toward lifting hold, says H.C. Wainwright
STTK Shattuck Labs
$28.31 /

+1.365 (+5.07%)

01/20/21 Citi
Shattuck Labs price target raised to $75 from $36 at Citi
01/11/21 Evercore ISI
Shattuck Labs initiated with an Outperform at Evercore ISI
11/03/20 Needham
Shattuck Labs initiated with a Buy at Needham
11/03/20 Citi
Shattuck Labs initiated with a Buy at Citi
VKTX Viking Therapeutics
$5.93 /

-0.23 (-3.73%)

02/18/21 Chardan
Chardan trims Viking Therapeutics target to $19 as COVID pushes out Voyage data
09/11/20 B. Riley FBR
Viking Therapeutics price target raised to $15 from $12 at B. Riley FBR
09/01/20 BTIG
Viking Therapeutics price target raised to $12 from $9 at BTIG
08/30/20 Chardan
Viking Therapeutics price target raised to $20 from $15 at Chardan
LMAT LeMaitre
$51.38 /

+0.82 (+1.62%)

IONS Ionis Pharmaceuticals
$42.32 /

-0.32 (-0.75%)

TSHA Taysha Gene Therapies
$21.35 /

+1.49 (+7.50%)

ZEAL Zealand Pharma
$33.60 /

+1.27 (+3.93%)

CLSD Clearside Biomedical
$2.66 /

+0.12 (+4.72%)

MEIP MEI Pharma
$3.43 /

+0.12 (+3.63%)

PCVX Vaxcyte
$20.27 /

-0.49 (-2.36%)

EVLO Evelo Biosciences
$10.03 /

+0.005 (+0.05%)

IVC Invacare
$8.23 /

-0.08 (-0.96%)

CYTK Cytokinetics
$24.17 /

+0.01 (+0.04%)

SYBX Synlogic
$3.34 /

-0.02 (-0.60%)

RNA Avidity Biosciences
$22.12 /

-1.8 (-7.53%)

CSTL Castle Biosciences
$69.44 /

-1.2 (-1.70%)

AGI Alamos Gold
$8.37 /

+0.08 (+0.97%)

CARA Cara Therapeutics
$29.09 /

+1.645 (+5.99%)

FIX Comfort Systems USA
$79.11 /

+1.925 (+2.49%)

ITRM Iterum Therapeutics
$1.30 /

-0.305 (-19.00%)

LTRN Lantern Pharma
$17.05 /

-0.13 (-0.76%)

OCGN Ocugen
$6.96 /

+0.045 (+0.65%)

QURE uniQure
$33.77 /

-1.75 (-4.93%)

STTK Shattuck Labs
$28.31 /

+1.365 (+5.07%)

VKTX Viking Therapeutics
$5.93 /

-0.23 (-3.73%)

  • 29
    Jan
  • 15
    Jan
  • 08
    Jan
  • 16
    Dec
  • 09
    Oct
  • 24
    Sep
  • 17
    Jul
  • 25
    Jun
  • 25
    Jun
  • 12
    Jun
  • 12
    Jun
  • 11
    Jun
OCGN Ocugen
$6.96 /

+0.045 (+0.65%)

GRCL Gracell
$13.52 /

-0.82 (-5.72%)

IONS Ionis Pharmaceuticals
$42.32 /

-0.32 (-0.75%)

MEIP MEI Pharma
$3.43 /

+0.12 (+3.63%)

PCVX Vaxcyte
$20.27 /

-0.49 (-2.36%)

SYBX Synlogic
$3.34 /

-0.02 (-0.60%)

CSTL Castle Biosciences
$69.44 /

-1.2 (-1.70%)

AGI Alamos Gold
$8.37 /

+0.08 (+0.97%)

CARA Cara Therapeutics
$29.09 /

+1.645 (+5.99%)

FIX Comfort Systems USA
$79.11 /

+1.925 (+2.49%)

ITRM Iterum Therapeutics
$1.30 /

-0.305 (-19.00%)

OCGN Ocugen
$6.96 /

+0.045 (+0.65%)

QURE uniQure
$33.77 /

-1.75 (-4.93%)

IONS Ionis Pharmaceuticals
$42.32 /

-0.32 (-0.75%)

PCVX Vaxcyte
$20.27 /

-0.49 (-2.36%)

EVLO Evelo Biosciences
$10.03 /

+0.005 (+0.05%)

BSGM BioSig Technologies
$4.59 /

+0.12 (+2.68%)

CYTK Cytokinetics
$24.17 /

+0.01 (+0.04%)

AGI Alamos Gold
$8.37 /

+0.08 (+0.97%)

LTRN Lantern Pharma
$17.05 /

-0.13 (-0.76%)

OCGN Ocugen
$6.96 /

+0.045 (+0.65%)

Friday
Hot Stocks
Mohawk Group closes previously announced debt refinancing » 08:35
04/09/21
04/09
08:35
04/09/21
08:35
MWK

Mohawk Group

$31.20 /

+2.29 (+7.92%)

Mohawk Group Holdings…

Mohawk Group Holdings announced that it has closed the refinancing of all of its previously outstanding debt, including two senior secured notes and its revolver credit facility. The Company previously announced its intent to refinance its outstanding debt on March 8, 2021. Pursuant to the refinancing, Mohawk issued senior secured promissory notes in an aggregate principal amount of $110M to two affiliated institutional lenders for a cash payment to Mohawk of $57.7M and the exchange of two senior secured promissory notes with an aggregate principal amount of $52.3M previously issued to the institutional lenders. $14.8M of the net proceeds were used to repay all amounts owed under the Company's Amended and Restated Credit and Security Agreement with MidCap Funding X Trust. The new senior secured promissory notes have an 8% annual interest rate payable in cash on a quarterly basis with a three year maturity. In connection with the refinancing, the Company issued to the institutional lenders warrants to purchase an aggregate of 2,259,166 shares of the Company's common stock with an exercise price of $31.74 per share. The Company expects to use the remaining net proceeds of $40.8M, after deducting fees and expenses, for potential acquisitions, working capital and general corporate purposes.

ShowHide Related Items >><<
MWK Mohawk Group
$31.20 /

+2.29 (+7.92%)

MWK Mohawk Group
$31.20 /

+2.29 (+7.92%)

04/05/21
Fly Intel: Top five analyst initiations
04/05/21 BTIG
Mohawk Group initiated with a Buy at BTIG
03/09/21 Roth Capital
Mohawk Group price target raised to $40 from $37 at Roth Capital
03/09/21 DA Davidson
Mohawk Group price target raised to $42 from $35 at DA Davidson
MWK Mohawk Group
$31.20 /

+2.29 (+7.92%)

MWK Mohawk Group
$31.20 /

+2.29 (+7.92%)

MWK Mohawk Group
$31.20 /

+2.29 (+7.92%)

Thursday
Hot Stocks
Waitr Holdings adds more Marco's Pizza delivery locations » 16:11
04/08/21
04/08
16:11
04/08/21
16:11
WTRH

Waitr Holdings

$2.80 /

+0.005 (+0.18%)

Waitr Holdings announced…

Waitr Holdings announced it has added additional Marco's Pizza locations to its platform. Waitr and Bite Squad now deliver from Marco's Pizza at more than 100 locations in 92 cities across the nation. The two companies originally began working together, in select markets, in October 2020. "Marco's Pizza's is dedicated to producing the best delivered pizza for its customers, and we're dedicated to make the best delivery experience, which makes it an ideal brand for the Waitr platform," said Carl Grimstad, CEO and Chairman of Waitr.

ShowHide Related Items >><<
WTRH Waitr Holdings
$2.80 /

+0.005 (+0.18%)

WTRH Waitr Holdings
$2.80 /

+0.005 (+0.18%)

03/08/21 Deutsche Bank
Waitr Holdings upgraded to Buy from Hold at Deutsche Bank
03/08/21 Deutsche Bank
Waitr Holdings upgraded to Buy from Hold at Deutsche Bank
03/05/21 B. Riley
Waitr share price offers opportunity ahead of results, says B. Riley
11/10/20 B. Riley
Waitr Holdings price target lowered to $7 from $8 at B. Riley Securities
WTRH Waitr Holdings
$2.80 /

+0.005 (+0.18%)

WTRH Waitr Holdings
$2.80 /

+0.005 (+0.18%)

WTRH Waitr Holdings
$2.80 /

+0.005 (+0.18%)

Options
Largest borrow rate increases among liquid names » 08:45
04/08/21
04/08
08:45
04/08/21
08:45
VLDR

Velodyne Lidar

$13.49 /

-0.74 (-5.20%)

, CLVR

Clever Leaves

$9.91 /

-0.46 (-4.44%)

, EYES

Second Sight

$8.29 /

-1.04 (-11.15%)

, WPRT

Westport

$6.78 /

-0.33 (-4.64%)

, BLNK

Blink Charging

$40.67 /

-2.27 (-5.29%)

, ABCL

AbCellera

$31.30 /

+2.28 (+7.86%)

, AMC

AMC Entertainment

$9.85 /

-0.34 (-3.34%)

, SRAX

Srax

$4.98 /

+0.17 (+3.53%)

, SUNW

Sunworks

$14.35 /

-0.975 (-6.36%)

, VET

Vermilion Energy

$7.00 /

-0.055 (-0.78%)

Latest data shows the…

Latest data shows the largest indicative borrow rate increases among liquid option names include: Velodyne Lidar (VLDR) 23.13% +5.34, Clever Leaves (CLVR) 28.13% +3.74, Second Sight (EYES) 57.97% +0.97, Westport (WPRT) 4.98% +0.82, Blink Charging (BLNK) 54.85% +0.71, AbCellera Biologics (ABCL) 21.40% +0.47, AMC Entertainment (AMC) 2.37% +0.35, Social Realty (SRAX) 30.15% +0.29, Sunworks (SUNW) 7.79% +0.22, and Vermilion Energy (VET) 1.73% +0.21.

ShowHide Related Items >><<
WPRT Westport
$6.78 /

-0.33 (-4.64%)

VLDR Velodyne Lidar
$13.49 /

-0.74 (-5.20%)

VET Vermilion Energy
$7.00 /

-0.055 (-0.78%)

SUNW Sunworks
$14.35 /

-0.975 (-6.36%)

SRAX Srax
$4.98 /

+0.17 (+3.53%)

EYES Second Sight
$8.29 /

-1.04 (-11.15%)

CLVR Clever Leaves
$9.91 /

-0.46 (-4.44%)

BLNK Blink Charging
$40.67 /

-2.27 (-5.29%)

AMC AMC Entertainment
$9.85 /

-0.34 (-3.34%)

ABCL AbCellera
$31.30 /

+2.28 (+7.86%)

VLDR Velodyne Lidar
$13.49 /

-0.74 (-5.20%)

03/30/21
Fly Intel: Top five analyst downgrades
03/30/21 Craig-Hallum
Velodyne downgraded to Hold at Craig-Hallum on lack of catalysts, Board drama
03/30/21 Craig-Hallum
Velodyne Lidar downgraded to Hold from Buy at Craig-Hallum
03/24/21 UBS
Apple recently granted patent for LiDAR system, says UBS
CLVR Clever Leaves
$9.91 /

-0.46 (-4.44%)

EYES Second Sight
$8.29 /

-1.04 (-11.15%)

WPRT Westport
$6.78 /

-0.33 (-4.64%)

03/18/21 Lake Street
Lake Street confidence in Westport's China ramp boosted by Weichai deal
03/17/21 H.C. Wainwright
Westport price target raised to $16 from $5 at H.C. Wainwright
02/08/21 Craig-Hallum
Clean Energy price target raised to $25 from $12 at Craig-Hallum
02/08/21 Craig-Hallum
Westport target raised to $24 following Amazon truck order, says Craig-Hallum
BLNK Blink Charging
$40.67 /

-2.27 (-5.29%)

03/08/21 Cowen
Blink Charging initiated with an Outperform at Cowen
02/05/21 Roth Capital
Blink Charging initiated with a Buy at Roth Capital
08/14/20
Fly Intel: Top five analyst downgrades
08/14/20 H.C. Wainwright
Blink Charging downgraded to Neutral from Buy at H.C. Wainwright
ABCL AbCellera
$31.30 /

+2.28 (+7.86%)

03/30/21 SVB Leerink
AbCellera price target lowered to $45 from $52 at SVB Leerink
03/24/21 BMO Capital
AbCellera price target lowered to $59 from $61 at BMO Capital
02/08/21 SVB Leerink
AbCellera price target raised to $52 from $45 at SVB Leerink
01/26/21 Berenberg
Eli Lilly data 'incrementally positive' for AbCellera, says Berenberg
AMC AMC Entertainment
$9.85 /

-0.34 (-3.34%)

04/05/21 B. Riley
B. Riley upgrades AMC to Buy with $13 target after 'impressive' weekend
04/05/21 B. Riley
AMC Entertainment upgraded to Buy from Neutral at B. Riley Securities
03/16/21 Citi
Citi keeps $2 target on AMC Entertainment, says shares overvalued
03/11/21 B. Riley
AMC Entertainment price target raised to $7 from $5.50 at B. Riley Securities
SRAX Srax
$4.98 /

+0.17 (+3.53%)

02/12/21 B. Riley
Srax price target raised to $7.50 from $4.50 at B. Riley Securities
02/08/21 Ladenburg
Srax initiated with a Buy at Ladenburg
01/29/21 B. Riley
Srax price target raised to $4.50 from $4 at B. Riley Securities
07/06/20
Fly Intel: Top five analyst initiations
SUNW Sunworks
$14.35 /

-0.975 (-6.36%)

12/21/20 Roth Capital
ITC/PTC extensions likely included in COVID relief package, says Roth Capital
12/15/20 Roth Capital
Solar tax credit extension would be positive surprise, says Roth Capital
VET Vermilion Energy
$7.00 /

-0.055 (-0.78%)

03/22/21 Scotiabank
Vermilion Energy price target raised to C$11.50 from C$9.25 at Scotiabank
03/10/21 TD Securities
Vermilion Energy price target raised to C$9.50 from C$6.50 at TD Securities
03/10/21 Canaccord
Vermilion Energy upgraded to Buy from Speculative Buy at Canaccord
03/09/21 CIBC
Vermilion Energy price target raised to C$10 from C$7 at CIBC
WPRT Westport
$6.78 /

-0.33 (-4.64%)

VLDR Velodyne Lidar
$13.49 /

-0.74 (-5.20%)

VET Vermilion Energy
$7.00 /

-0.055 (-0.78%)

SRAX Srax
$4.98 /

+0.17 (+3.53%)

BLNK Blink Charging
$40.67 /

-2.27 (-5.29%)

AMC AMC Entertainment
$9.85 /

-0.34 (-3.34%)

ABCL AbCellera
$31.30 /

+2.28 (+7.86%)

  • 08
    Jan
  • 11
    Dec
  • 01
    May
WPRT Westport
$6.78 /

-0.33 (-4.64%)

VLDR Velodyne Lidar
$13.49 /

-0.74 (-5.20%)

BLNK Blink Charging
$40.67 /

-2.27 (-5.29%)

AMC AMC Entertainment
$9.85 /

-0.34 (-3.34%)

WPRT Westport
$6.78 /

-0.33 (-4.64%)

VLDR Velodyne Lidar
$13.49 /

-0.74 (-5.20%)

VET Vermilion Energy
$7.00 /

-0.055 (-0.78%)

SUNW Sunworks
$14.35 /

-0.975 (-6.36%)

SRAX Srax
$4.98 /

+0.17 (+3.53%)

EYES Second Sight
$8.29 /

-1.04 (-11.15%)

CLVR Clever Leaves
$9.91 /

-0.46 (-4.44%)

BLNK Blink Charging
$40.67 /

-2.27 (-5.29%)

AMC AMC Entertainment
$9.85 /

-0.34 (-3.34%)

ABCL AbCellera
$31.30 /

+2.28 (+7.86%)

WPRT Westport
$6.78 /

-0.33 (-4.64%)

VLDR Velodyne Lidar
$13.49 /

-0.74 (-5.20%)

SUNW Sunworks
$14.35 /

-0.975 (-6.36%)

EYES Second Sight
$8.29 /

-1.04 (-11.15%)

CLVR Clever Leaves
$9.91 /

-0.46 (-4.44%)

BLNK Blink Charging
$40.67 /

-2.27 (-5.29%)

AMC AMC Entertainment
$9.85 /

-0.34 (-3.34%)

ABCL AbCellera
$31.30 /

+2.28 (+7.86%)

Wednesday
Syndicate
INVO Bioscience files $35M mixed securities shelf  16:42
04/07/21
04/07
16:42
04/07/21
16:42
INVO

INVO Bioscience

$4.13 /

-0.1 (-2.36%)

 
ShowHide Related Items >><<
INVO INVO Bioscience
$4.13 /

-0.1 (-2.36%)

INVO INVO Bioscience
$4.13 /

-0.1 (-2.36%)

12/29/20 Roth Capital
Roth Capital starts INVO Bioscience with Buy, $5.75 price target
12/29/20 Roth Capital
INVO Bioscience initiated with a Buy at Roth Capital
12/15/20 Colliers
INVO Bioscience initiated with a Buy at Colliers
INVO INVO Bioscience
$4.13 /

-0.1 (-2.36%)

Conference/Events
Avid Bioservices participates in a conference call with Stephens » 15:55
04/07/21
04/07
15:55
04/07/21
15:55
CDMO

Avid Bioservices

$19.37 /

-0.11 (-0.56%)

Conference call with CEO…

Conference call with CEO Green and CFO Hart will be held on April 7 at 4 pm hosted by Stephens.

ShowHide Related Items >><<
CDMO Avid Bioservices
$19.37 /

-0.11 (-0.56%)

CDMO Avid Bioservices
$19.37 /

-0.11 (-0.56%)

03/29/21 RBC Capital
Humanigen lenzilumab update 'an incremental positive' for Avid, says RBC Capital
03/16/21 RBC Capital
RBC starts Avid Bioservices at Outperform with $21 price target
03/16/21 RBC Capital
Avid Bioservices initiated with an Outperform at RBC Capital
02/01/21 KeyBanc
Avid Bioservices price target raised to $22 from $12 at KeyBanc
CDMO Avid Bioservices
$19.37 /

-0.11 (-0.56%)

  • 10
    Dec
CDMO Avid Bioservices
$19.37 /

-0.11 (-0.56%)

Upgrade
Fly Intel: Top five analyst upgrades » 09:56
04/07/21
04/07
09:56
04/07/21
09:56
NCMI

National CineMedia

$4.85 /

+0.2 (+4.30%)

, FOXA

Fox Corp.

$37.81 /

+0.8 (+2.16%)

, GSX

GSX Techedu

$32.43 /

-0.4 (-1.22%)

, LAZ

Lazard

$46.61 /

+1.87 (+4.18%)

, ANF

Abercrombie & Fitch

$37.13 /

+1.98 (+5.63%)

, GIL

Gildan Activewear

$33.06 /

+0.86 (+2.67%)

, KTB

Kontoor Brands

$53.80 /

+3.29 (+6.51%)

, LB

L Brands

$63.41 /

+1.36 (+2.19%)

Catch up on today's…

Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. National CineMedia (NCMI) upgraded to Buy from Hold at Benchmark with analyst Mike Hickey saying he believes the domestic theatrical business is "poised to make a resounding post-pandemic growth reset." 2. Fox Corp. (FOXA) upgraded to Equal Weight from Underweight at Wells Fargo with analyst Steven Cahall saying he now sees the new NFL deal as a clearing event with the firm's out-year TV estimates moving up significantly. 3. GSX Techedu (GSX) upgraded to Neutral from Underweight at JPMorgan with analyst DS Kim saying while "myriads of uncertainty" still exist, technical selling pressure should subside "sooner or later," which alone could push the stock higher. 4. Lazard (LAZ) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Manan Gosalia saying industry M&A activity is "booming," with global announced M&A volumes reaching $1.4T for the second quarter in a row in Q1 to mark the new high since the financial crisis adding that Lazard gets about 55% of its revenues from M&A and capital markets advisory. 5. Abercrombie & Fitch (ANF), Gildan Activewear (GILD), Kontoor Brands (KTB) and L Brands (LB) all upgraded to Buy from Neutral at UBS. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

ShowHide Related Items >><<
NCMI National CineMedia
$4.85 /

+0.2 (+4.30%)

LB L Brands
$63.41 /

+1.36 (+2.19%)

LAZ Lazard
$46.61 /

+1.87 (+4.18%)

KTB Kontoor Brands
$53.80 /

+3.29 (+6.51%)

GSX GSX Techedu
$32.43 /

-0.4 (-1.22%)

GIL Gildan Activewear
$33.06 /

+0.86 (+2.67%)

FOXA Fox Corp.
$37.81 /

+0.8 (+2.16%)

ANF Abercrombie & Fitch
$37.13 /

+1.98 (+5.63%)

NCMI National CineMedia
$4.85 /

+0.2 (+4.30%)

04/07/21 Benchmark
National CineMedia upgraded to Buy from Hold at Benchmark
03/24/21 B. Riley
Disney 'day-and-date' decision negative for exhibitors, says B. Riley
01/26/21 B. Riley
National CineMedia price target raised to $6 from $4.50 at B. Riley Securities
12/28/20 B. Riley
'Wonder Women' opens well above expectations, says B. Riley Securities
FOXA Fox Corp.
$37.81 /

+0.8 (+2.16%)

04/07/21 Wells Fargo
Fox Corp. upgraded to Equal Weight from Underweight at Wells Fargo
04/07/21 Wells Fargo
Fox Corp. upgraded to Equal Weight from Underweight at Wells Fargo
03/29/21 Barclays
Fox Corp. price target raised to $38 from $29 at Barclays
03/25/21 MoffettNathanson
Fox Corp. price target raised to $50 from $40 at MoffettNathanson
GSX GSX Techedu
$32.43 /

-0.4 (-1.22%)

04/07/21 JPMorgan
GSX Techedu upgraded to Neutral from Underweight at JPMorgan
03/29/21
Fly Intel: Top five analyst upgrades
03/29/21 Citi
Citi double upgrades GSX Techedu to Buy after Friday's 'overdone' selloff
03/29/21 Citi
GSX Techedu upgraded to Buy from Sell at Citi
LAZ Lazard
$46.61 /

+1.87 (+4.18%)

04/07/21 Morgan Stanley
Morgan Stanley upgrades Lazard to Overweight with M&A 'booming'
04/07/21 Morgan Stanley
Lazard upgraded to Overweight from Equal Weight at Morgan Stanley
02/09/21 Argus
Lazard price target raised to $48 from $40 at Argus
01/14/21 Keefe Bruyette
Lazard downgraded to Market Perform from Outperform at Keefe Bruyette
ANF Abercrombie & Fitch
$37.13 /

+1.98 (+5.63%)

04/07/21 UBS
Abercrombie & Fitch upgraded to Buy with $46 target at UBS
04/07/21 UBS
Abercrombie & Fitch upgraded to Buy from Neutral at UBS
03/24/21 B. Riley
Abercrombie & Fitch price target raised to $38 from $31 at B. Riley
03/04/21 Wedbush
Abercrombie & Fitch price target raised to $33 from $18 at Wedbush
GIL Gildan Activewear
$33.06 /

+0.86 (+2.67%)

04/07/21 UBS
Gildan Activewear upgraded to Buy with $43 target at UBS
04/07/21 UBS
Gildan Activewear upgraded to Buy from Neutral at UBS
03/01/21 Desjardins
Gildan Activewear price target raised to C$45 from C$40 at Desjardins
03/01/21 National Bank
Gildan Activewear price target raised to C$43 from C$40 at National Bank
KTB Kontoor Brands
$53.80 /

+3.29 (+6.51%)

04/07/21 UBS
Kontoor Brands upgraded to Buy with $74 target at UBS
04/07/21 UBS
Kontoor Brands upgraded to Buy from Neutral at UBS
12/30/20 Guggenheim
Kontoor Brands price target raised to $46 from $40 at Guggenheim
12/10/20 Goldman Sachs
Kontoor Brands downgraded to Neutral from Buy at Goldman Sachs
LB L Brands
$63.41 /

+1.36 (+2.19%)

04/07/21 UBS
L Brands upgraded to Buy with $96 target at UBS
04/07/21 UBS
L Brands upgraded to Buy from Neutral at UBS
03/30/21 MKM Partners
L Brands price target raised to $85 from $83 at MKM Partners
03/30/21 Morgan Stanley
L Brands price target raised to $73 from $68 at Morgan Stanley
NCMI National CineMedia
$4.85 /

+0.2 (+4.30%)

LB L Brands
$63.41 /

+1.36 (+2.19%)

LAZ Lazard
$46.61 /

+1.87 (+4.18%)

KTB Kontoor Brands
$53.80 /

+3.29 (+6.51%)

GSX GSX Techedu
$32.43 /

-0.4 (-1.22%)

GIL Gildan Activewear
$33.06 /

+0.86 (+2.67%)

FOXA Fox Corp.
$37.81 /

+0.8 (+2.16%)

ANF Abercrombie & Fitch
$37.13 /

+1.98 (+5.63%)

NCMI National CineMedia
$4.85 /

+0.2 (+4.30%)

LB L Brands
$63.41 /

+1.36 (+2.19%)

LAZ Lazard
$46.61 /

+1.87 (+4.18%)

GSX GSX Techedu
$32.43 /

-0.4 (-1.22%)

FOXA Fox Corp.
$37.81 /

+0.8 (+2.16%)

NCMI National CineMedia
$4.85 /

+0.2 (+4.30%)

LB L Brands
$63.41 /

+1.36 (+2.19%)

LAZ Lazard
$46.61 /

+1.87 (+4.18%)

GSX GSX Techedu
$32.43 /

-0.4 (-1.22%)

FOXA Fox Corp.
$37.81 /

+0.8 (+2.16%)

ANF Abercrombie & Fitch
$37.13 /

+1.98 (+5.63%)

LB L Brands
$63.41 /

+1.36 (+2.19%)

GSX GSX Techedu
$32.43 /

-0.4 (-1.22%)

FOXA Fox Corp.
$37.81 /

+0.8 (+2.16%)

ANF Abercrombie & Fitch
$37.13 /

+1.98 (+5.63%)

Recommendations
Acadia price target lowered to $30 from $44 at Needham » 08:52
04/07/21
04/07
08:52
04/07/21
08:52
ACAD

Acadia

$20.64 /

-0.52 (-2.46%)

Needham analyst Joseph…

Needham analyst Joseph Stringer lowered the firm's price target on Acadia to $30 from $44 but keeps a Buy rating on the shares. The news of an FDA Complete Response Letter for Nuplazid in Dementia-Related Psychosis was mostly as expected as it had previously identified deficiencies in the sNDA, though the issues raised are significant and include concerns around a broad DRP label based on the Ph3 HARMONY trial, the analyst tells investors in a research note. Stringer adds that he is lowering his Dementia-Related Psychosis indication probability of success to 20% from 60%.

ShowHide Related Items >><<
ACAD Acadia
$20.64 /

-0.52 (-2.46%)

ACAD Acadia
$20.64 /

-0.52 (-2.46%)

04/07/21 H.C. Wainwright
Acadia downgraded to Neutral from Buy at H.C. Wainwright
04/06/21 SVB Leerink
Acadia price target lowered to $31 from $63 at SVB Leerink
04/06/21 Jefferies
Acadia downgraded to Hold at Jefferies after dementia-related psychosis CRL
04/06/21 Morgan Stanley
Acadia price target lowered to $28 from $50 at Morgan Stanley
ACAD Acadia
$20.64 /

-0.52 (-2.46%)

ACAD Acadia
$20.64 /

-0.52 (-2.46%)

Upgrade
National CineMedia upgraded to Buy from Hold at Benchmark » 06:24
04/07/21
04/07
06:24
04/07/21
06:24
NCMI

National CineMedia

$4.66 /

-0.04 (-0.85%)

Benchmark analyst Mike…

Benchmark analyst Mike Hickey upgraded National CineMedia to Buy from Hold with a $6 price target. The analyst believes the domestic theatrical business is "poised to make a resounding post-pandemic growth reset." With the resurgence of movie-goers, National CineMedia will directly benefit as "newly energized" cinema media buyers re-engage with an "elusive and compelling demographic," Hickey tells investors in a research note. He believes virus mitigation efforts has inflected in the U.S., which will drive an "accelerated trend toward a desire for normality, escapism and out of home entertainment." National CineMedia can rebuild pre-pandemic EBITDA levels, and benefit from digital out of home initiatives, says Hickey. The stock offers a "hypothetical 100% pre-pandemic return potential."

ShowHide Related Items >><<
NCMI National CineMedia
$4.66 /

-0.04 (-0.85%)

NCMI National CineMedia
$4.66 /

-0.04 (-0.85%)

03/24/21 B. Riley
Disney 'day-and-date' decision negative for exhibitors, says B. Riley
01/26/21 B. Riley
National CineMedia price target raised to $6 from $4.50 at B. Riley Securities
12/28/20 B. Riley
'Wonder Women' opens well above expectations, says B. Riley Securities
12/04/20 B. Riley
Theater selloff on Warner Bros. news likely an overreaction, says B. Riley
NCMI National CineMedia
$4.66 /

-0.04 (-0.85%)

NCMI National CineMedia
$4.66 /

-0.04 (-0.85%)

NCMI National CineMedia
$4.66 /

-0.04 (-0.85%)

Downgrade
Acadia downgraded to Neutral from Buy at H.C. Wainwright » 06:11
04/07/21
04/07
06:11
04/07/21
06:11
ACAD

Acadia

$20.64 /

-0.52 (-2.46%)

H.C. Wainwright analyst…

H.C. Wainwright analyst Andrew Fein downgraded Acadia Pharmaceuticals to Neutral from Buy with a price target of $18, down from $43. Based on the Complete Response Letter, the analyst believes Acadia "completely failed to appreciate" the FDA's advice at the end of the Phase 2 meeting, which "clearly stated" that a single well-controlled study must be very persuasive, offer statistical significance with a very small probability of Type I error, and that it should be clinically meaningful. Failure to fully appreciate a prospective worst-case scenario following the FDA meeting has resulted in just that, Fein tells investors in a research note.

ShowHide Related Items >><<
ACAD Acadia
$20.64 /

-0.52 (-2.46%)

ACAD Acadia
$20.64 /

-0.52 (-2.46%)

04/06/21 SVB Leerink
Acadia price target lowered to $31 from $63 at SVB Leerink
04/06/21 Jefferies
Acadia downgraded to Hold at Jefferies after dementia-related psychosis CRL
04/06/21 Morgan Stanley
Acadia price target lowered to $28 from $50 at Morgan Stanley
04/06/21 Canaccord
Canaccord downgrades Acadia to Hold on Nuplazid uncertainty
ACAD Acadia
$20.64 /

-0.52 (-2.46%)

ACAD Acadia
$20.64 /

-0.52 (-2.46%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.